Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Activity Overview

In this online, on-demand educational video, Gus Alva, MD, DFAPA; and Erin Crown, MHS, PA-C will discuss the utility of oral antipsychotics for the treatment of newly diagnosed and previously treated patients with schizophrenia. The expert faculty will review the importance of shared decision-making, treatment adherence, and treatment switching therapies. Case studies will be reviewed to help illustrate how oral antipsychotics can be incorporated into daily practice.

Target Audience

This educational activity is directed toward psychiatrists, nurse practitioners, physician assistants, and nurses who specialize in treating patients with schizophrenia.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Evaluate clinical trial data for new and emerging agents for schizophrenia
• Incorporate approved agents into management plans for patients with schizophrenia
• Design individualized treatment plans for patients with schizophrenia using shared decision-making principles